In vitro human helper T-cell assay to screen antibody drug candidates for immunogenicity
Monoclonal antibody (mAb) drugs offer a number of valuable treatments. Many newly developed mAb drugs include artificial modification of amino acid sequences from human origin, which may cause higher immunogenicity to induce anti-drug antibodies (ADA). If the immunogenicity of a new candidate can be...
Prif Awduron: | , , , , , , , , , , |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Taylor & Francis Group
2019-01-01
|
Cyfres: | Journal of Immunotoxicology |
Pynciau: | |
Mynediad Ar-lein: | http://dx.doi.org/10.1080/1547691X.2019.1604586 |